Brief exposure to Rapamycin, a promising anti-aging drug that has positive effects on health and lifespan, has the same effect as long-term exposure to the drug in animal models. The findings pave the way for testing the effects of short-term rapamycin exposure on the lifespan of humans.
Recent clinical trials show urolithin A, a compound derived from molecules in pomegranates, can slow the aging process. Urolithin A improves mitochondrial function following oral consumption.
Researchers discover an experimental Alzheimer's disease drug appears to slow key features of the aging process, including memory loss and improved a number of physiological features.